ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Phosgene → HCID 67515133、化合物

HRID 473904
印刷

反応式

HRID 473904 の反応式
[O:1]1[C:7]2[CH:8]=[CH:9][C:10]([C:12]3[CH:17]=[CH:16][C:15]([C:18]4[N:19]([C:23]([O:25][CH2:26][CH:27]([CH3:29])[CH3:28])=[O:24])[CH:20]=[CH:21][N:22]=4)=[CH:14][CH:13]=3)=[CH:11][C:6]=2[CH2:5][NH:4][CH2:3][CH2:2]1.CCN(C(C)C)C(C)C.[C:39](Cl)(Cl)=[O:40].Cl.[C:44]([CH:46]1[CH2:51][CH2:50][NH:49][CH2:48][CH2:47]1)#[N:45]>ClCCl>[C:44]([CH:46]1[CH2:51][CH2:50][N:49]([C:39]([N:4]2[CH2:5][C:6]3[CH:11]=[C:10]([C:12]4[CH:13]=[CH:14][C:15]([C:18]5[N:19]([C:23]([O:25][CH2:26][CH:27]([CH3:29])[CH3:28])=[O:24])[CH:20]=[CH:21][N:22]=5)=[CH:16][CH:17]=4)[CH:9]=[CH:8][C:7]=3[O:1][CH2:2][CH2:3]2)=[O:40])[CH2:48][CH2:47]1)#[N:45]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 6371PhosgeneHCID 81531Diisopropylethylamine2 回HCID 227446374-Piperidinecarbonitrile hydrochlorideHCID 67513954HCID 67513954、化合物

生成物 1

HCID 67515133HCID 67515133、化合物収率 61%

試薬・触媒・溶媒 1

HCID 6344
Dichloromethane
溶媒
2 回

反応条件

温度
0 °C

実験手順

2-methylpropyl 2-[4-(2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)phenyl]-1H-imidazole-1-carboxylate (361 mg, 0.92 mmol) was taken into dichloromethane (5 mL) followed by addition of DIPEA (0.32 mL, 1.84 mmol). The solution thus obtained was added slowly by syringe over several minutes to a solution of phosgene (20 W % in toluene, 0.49 mL, 0.93 mmol) diluted in dichloromethane (5 mL) and cooled to 0° C. The resulting mixture was stirred for 5 minutes then allowed to warm to room temperature and concentrated. The residue was taken back into dichloromethane (5 mL) followed by addition of DIPEA (0.48 mL, 2.76 mmol) and 4-cyanopiperidine hydrochloride salt (156 mg, 1.06 mmol) then stirred for 12 h. The mixture was concentrated then partitioned with ethyl acetate and 10% aqueous citric acid. The organic solution was washed with brine, dried over anhydrous sodium sulfate then filtered and concentrated. The residue was purified by silica gel chromatography (100% ethyl acetate) to give 2-methylpropyl 2-(4-{4-[(4-cyanopiperidin-1-yl)carbonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}phenyl)-1H-imidazole-1-carboxylate (296 mg, 61% yield) as a crystalline solid. MS (EI) for C30H33N5O4: 529 (MH+).

後処理

  1. customThe solution thus obtained
  2. temperatureto warm to room temperature
  3. concentrationconcentrated
  4. stirringthen stirred for 12 h
  5. concentrationThe mixture was concentrated
  6. customthen partitioned with ethyl acetate and 10% aqueous citric acid
  7. washThe organic solution was washed with brine
  8. dry with materialdried over anhydrous sodium sulfate
  9. filtrationthen filtered
  10. concentrationconcentrated
  11. customThe residue was purified by silica gel chromatography (100% ethyl acetate)

出典と根拠

ORDレコード
ord-1f6edd0b9e5248709d61f42edf95c663
出典データセット
uspto-grants-2014_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08637499B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート